Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shien Guo

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Inorganic Chemistry|November 23, 2022
Hierarchical S-Scheme Heterostructure of CdIn<sub>2</sub>S<sub>4</sub>@UiO-66-NH<sub>2</sub> toward Synchronously Boosting Photocatalytic Removal of Cr(VI) and TetracyclineJiale He, Jianqiang Hu, Yingfei Hu, et al.
Chemsuschem|April 16, 2020
Direct Z-Scheme Heterojunction of SnS<sub>2</sub> /Sulfur-Bridged Covalent Triazine Frameworks for Visible-Light-Driven CO<sub>2</sub> PhotoreductionShien Guo, Peng Yang, Yanfei Zhao, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 13, 2018
The Effect of Lenalidomide on Health-Related Quality of Life in Patients With Lower-Risk Non-del(5q) Myelodysplastic Syndromes: Results From the MDS-005 StudyValeria Santini, Antonio Almeida, Aristoteles Giagounidis, et al.
Angewandte Chemie (International Ed. in English)|December 15, 2018
Eosin Y-Functionalized Conjugated Organic Polymers for Visible-Light-Driven CO<sub>2</sub> Reduction with H<sub>2</sub> O to CO with High EfficiencyXiaoxiao Yu, Zhenzhen Yang, Bing Qiu, et al.
The American Journal of Cardiology|January 1, 2026
Patient-Reported Outcomes Using Win Ratio Analysis: A Post Hoc Analysis From The Randomized ENVISAGE-TAVI AF TrialChristian Hengstenberg, Nicolas M Van Mieghem, Rosa Wang, et al.
BMC Psychiatry|August 11, 2023
Esketamine versus placebo on time to remission in major depressive disorder with acute suicidalityDong-Jing Fu, Qiaoyi Zhang, Ling Shi, et al.
Journal of Patient-Reported Outcomes|August 12, 2024
The Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-Fatigue) scale in patients with axial spondyloarthritis: psychometric properties and clinically meaningful thresholds for interpretationDavid Cella, Christine de la Loge, Fatoumata Fofana, et al.
The American Journal of Cardiology|October 17, 2023
Treatment Satisfaction and Convenience for Patients With Atrial Fibrillation on Edoxaban or Vitamin K Antagonists After Transcatheter Aortic Valve Replacement: A Post Hoc Analysis from the ENVISAGE-TAVI AF TrialChristian Hengstenberg, Nicolas M Van Mieghem, Rosa Wang, et al.
Haematologica|August 30, 2023
Lisocabtagene maraleucel for second-line relapsed or refractory large B-cell lymphoma: patient-reported outcomes from the PILOT studyLeo I Gordon, Fei Fei Liu, Julia Braverman, et al.
Blood Advances|December 21, 2021
Health-related quality of life with idecabtagene vicleucel in relapsed and refractory multiple myelomaMichel Delforge, Nina Shah, Jesús San F Miguel, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Inorganic Chemistry|November 23, 2022
Hierarchical S-Scheme Heterostructure of CdIn<sub>2</sub>S<sub>4</sub>@UiO-66-NH<sub>2</sub> toward Synchronously Boosting Photocatalytic Removal of Cr(VI) and TetracyclineJiale He, Jianqiang Hu, Yingfei Hu, et al.
Chemsuschem|April 16, 2020
Direct Z-Scheme Heterojunction of SnS<sub>2</sub> /Sulfur-Bridged Covalent Triazine Frameworks for Visible-Light-Driven CO<sub>2</sub> PhotoreductionShien Guo, Peng Yang, Yanfei Zhao, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 13, 2018
The Effect of Lenalidomide on Health-Related Quality of Life in Patients With Lower-Risk Non-del(5q) Myelodysplastic Syndromes: Results From the MDS-005 StudyValeria Santini, Antonio Almeida, Aristoteles Giagounidis, et al.
Angewandte Chemie (International Ed. in English)|December 15, 2018
Eosin Y-Functionalized Conjugated Organic Polymers for Visible-Light-Driven CO<sub>2</sub> Reduction with H<sub>2</sub> O to CO with High EfficiencyXiaoxiao Yu, Zhenzhen Yang, Bing Qiu, et al.
The American Journal of Cardiology|January 1, 2026
Patient-Reported Outcomes Using Win Ratio Analysis: A Post Hoc Analysis From The Randomized ENVISAGE-TAVI AF TrialChristian Hengstenberg, Nicolas M Van Mieghem, Rosa Wang, et al.
BMC Psychiatry|August 11, 2023
Esketamine versus placebo on time to remission in major depressive disorder with acute suicidalityDong-Jing Fu, Qiaoyi Zhang, Ling Shi, et al.
Journal of Patient-Reported Outcomes|August 12, 2024
The Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-Fatigue) scale in patients with axial spondyloarthritis: psychometric properties and clinically meaningful thresholds for interpretationDavid Cella, Christine de la Loge, Fatoumata Fofana, et al.
The American Journal of Cardiology|October 17, 2023
Treatment Satisfaction and Convenience for Patients With Atrial Fibrillation on Edoxaban or Vitamin K Antagonists After Transcatheter Aortic Valve Replacement: A Post Hoc Analysis from the ENVISAGE-TAVI AF TrialChristian Hengstenberg, Nicolas M Van Mieghem, Rosa Wang, et al.
Haematologica|August 30, 2023
Lisocabtagene maraleucel for second-line relapsed or refractory large B-cell lymphoma: patient-reported outcomes from the PILOT studyLeo I Gordon, Fei Fei Liu, Julia Braverman, et al.
Blood Advances|December 21, 2021
Health-related quality of life with idecabtagene vicleucel in relapsed and refractory multiple myelomaMichel Delforge, Nina Shah, Jesús San F Miguel, et al.
Pageof 7